MARSHIL LOCKLEAR: Open Payments
NPI 1053897611 · LUMBERTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,320 in 59 payments from 18 companies in 2025. Trend: 2023 $458 · 2024 $664 · 2025 $1,320
Food & beverage: $1,320
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $524 |
| Lilly USA, LLC | 7 | $200 |
| Bayer Healthcare Pharmaceuticals Inc. | 15 | $166 |
| Paratek Pharmaceuticals, Inc. | 5 | $91 |
| REVANCE THERAPEUTICS, INC. | 1 | $61 |
| Insulet Corporation | 2 | $47 |
| Astellas Pharma US Inc | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Ardelyx, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $21 |
Products named: Wegovy, Kerendia, Ozempic, ZEPBOUND, MOUNJARO, NUZYRA, DAXXIFY, Omnipod.
Industry payments across NC — which companies pay providers there.
